Theranos general counsel Heather King told the Journal last year that Mr. Balwani’s instructions were consistent with the company’s “alternative assessment procedures,” which it said it adopted because it believes its unique technology has no peer group and could be thrown off by the preservatives used in proficiency-testing samples.
It's really Theranoax.